Cosmos Health Inc. (COSM) stock
COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30107% above fair value
$2.95+0.10 (+3.51%)
Close on Nov 18, 2026Market cap $296.87MP/E –Yield –
Cosmos Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cosmos Health's operating income for the twelve months ending Jun 30, 2026 was -$18.33M. For fiscal 2025 it was -$16.70M. The highest annual figure on record is $7.12M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$16.70M | – |
| FY2024 | Dec 31, 2024 | -$15.54M | – |
| FY2023 | Dec 31, 2023 | -$21.83M | – |
| FY2022 | Dec 31, 2022 | -$7.47M | – |
| FY2021 | Dec 31, 2021 | -$4.53M | -267.0% |
| FY2020 | Dec 31, 2020 | $2.71M | – |
| FY2019 | Dec 31, 2019 | -$255.81K | – |
| FY2018 | Dec 31, 2018 | -$1.23M | – |
| FY2017 | Dec 31, 2017 | -$4.87M | – |
| FY2016 | Dec 31, 2016 | -$202.51K | – |
| FY2015 | Dec 31, 2015 | -$442.46K | -106.2% |
| FY2014 | Dec 31, 2014 | $7.12M | – |
| FY2012 | Jul 31, 2012 | -$330.59K | – |
| FY2011 | Jul 31, 2011 | -$169.25K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.93M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.18M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.65M | – |
| Q1 FY2025 | Mar 31, 2025 | -$833.15K | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.97M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.59M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.02M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.58M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.65M | -1194.4% |
| Q4 FY2022 | Dec 31, 2022 | -$7.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$344.11K | – |
| Q2 FY2022 | Jun 30, 2022 | -$74.36K | -117.6% |
| Q1 FY2022 | Mar 31, 2022 | $242.25K | -77.6% |
| Q4 FY2021 | Dec 31, 2021 | -$511.28K | -151.8% |
| Q1 FY2021 | Mar 31, 2021 | -$1.73M | -867.5% |
| Q4 FY2020 | Dec 31, 2020 | $422.41K | -24.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.08M | – |
| Q2 FY2020 | Jun 30, 2020 | $986.31K | – |
| Q1 FY2020 | Mar 31, 2020 | $225.56K | – |
| Q4 FY2019 | Dec 31, 2019 | $560.38K | – |
| Q3 FY2019 | Sep 30, 2019 | -$116.56K | -380.9% |
| Q2 FY2019 | Jun 30, 2019 | -$525.89K | – |
| Q1 FY2019 | Mar 31, 2019 | -$173.74K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.04M | – |
| Q3 FY2018 | Sep 30, 2018 | $41.49K | +152.3% |
| Q2 FY2018 | Jun 30, 2018 | -$78.79K | – |
| Q1 FY2018 | Mar 31, 2018 | -$149.55K | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.11M | – |
| Q3 FY2017 | Sep 30, 2017 | $16.45K | – |
| Q2 FY2017 | Jun 30, 2017 | -$796.64K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.98M | – |
| Q4 FY2016 | Dec 31, 2016 | -$43.59K | – |
| Q3 FY2016 | Sep 30, 2016 | -$30.97K | – |
| Q2 FY2016 | Jun 30, 2016 | -$86.93K | – |
See a number that looks wrong?